FDA Approves Expanded Indication for Merck’s KEYTRUDA in Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Merck, known as MSD outside the United States and Canada, announced that the U.S. FDA has approved an expanded label for KEYTRUDA, Merck’s anti-PD-1...
Blueprint and Roche Take on Lilly As FDA Approves RET-Targeting Lung Cancer Drug
Cancer drugs firm Blueprint Medicines has gained a second US approval, with its Gavreto (pralsetinib) daily pill that targets non-small cell lung cancer with...
Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Roche announced U.S. FDA approval for the expanded use of CINtec® PLUS Cytology, the first triage test based on biomarker technology for women whose...
Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trial of STI-1499 Neutralizing Antibody in COVID-19 Positive Patients
Sorrento Therapeutics, Inc. announced that it received a study may proceed letter from the FDA for its phase 1 clinical trial for COVI-GUARD (STI-1499)...
Merck’s KEYTRUDA Receives Two New Approvals in Japan
Merck , known as MSD outside the United States and Canada, announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has received two new approvals from the...
Gileads Kite bags second CAR-T okay with Tecartus nod in mantle cell lymphoma
Kite, a Gilead Company announced that the U.S. FDA has granted accelerated approval to Tecartus™ (brexucabtagene autoleucel, formerly KTE-X19), the first and only approved...
FDA Approves Expanded BOTOX Label for the Treatment of Pediatric Patients with Spasticity
Allergan, an AbbVie company, announced that the U.S. FDA approved a supplemental Biologics License Application (sBLA) that supports expanded use of BOTOX® for the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...